跨性别及性别多元人群子宫内膜异位症影像学研究(ETRIS)
该多中心回顾性队列研究纳入2021至2024年荷兰与英国三家学术医疗中心325例出生时指定女性(AFAB)的跨性别及性别多元(TGD)个体,评估腹腔镜盆腔手术后病理确诊的子宫内膜异位症患病率,结果为3.1%(n=10),平均年龄27.2岁,平均BMI 24.9,95.4%术前使用睾酮,其中38.5%使用睾酮5年及以上,6%报告痛经,子宫内膜异位症患者中30%有痛经。作者认为该患病率低于既往文献报道的顺性别女性及其他TGD人群研究,可能与长期使用睾酮及早期启动性别肯定医疗(GAC)有关。
要点
- AFAB的TGD个体腹腔镜手术后确诊子宫内膜异位症患病率为3.1%(n=10/325)。
- 95.4%术前使用睾酮,其中38.5%使用睾酮5年及以上。
- 子宫内膜异位症患者中30%报告痛经,总体样本中6%报告痛经。
核心结论
- 样本中子宫内膜异位症患病率为3.1%,低于既往文献报道的顺性别女性及其他TGD人群研究,可能与长期使用睾酮及早期启动性别肯定医疗有关。
研究设计与样本
- 2021至2024年荷兰与英国三家学术医疗中心开展的多中心回顾性队列研究。
- 纳入325例年龄≥18岁、因任何指征(包括性别不一致/性别烦躁)接受腹腔镜盆腔手术的AFAB的TGD个体。
主要发现
- 325例参与者中子宫内膜异位症患病率为3.1%(n=10)。
- 参与者平均年龄27.2岁,平均BMI 24.9。
- 95.4%术前使用睾酮,其中38.5%在手术时已使用睾酮5年及以上。
- 总体样本中6%报告痛经,子宫内膜异位症患者中30%报告痛经。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the prevalence of surgically confirmed endometriosis among assigned-female-at-birth (AFAB) transgender and gender diverse (TGD) individuals undergoing laparoscopic pelvic surgery. DESIGN: Retrospective multicenter cohort study from 2021 to 2024. SETTING: Three academic medical centers in the Netherlands and the United Kingdom. PARTICIPANTS: Eligible participants were AFAB TGD individuals aged ≥18 years who underwent pelvic laparoscopic surgery for any indication, including gender incongruence/dysphoria. INTERVENTIONS: Data on demographics, medical history, and diagnostic imaging were analyzed using descriptive statistics. Surgical confirmation of endometriosis was the primary outcome. RESULTS: Among 325 participants, endometriosis prevalence was 3.1% (n = 10). The mean age of participants was 27.2 years and the mean body mass index (BMI) 24.9. Testosterone was predominantly used before surgery (95.4%), and among these users, 38.5% had been on testosterone for 5 or more years at the time of surgery. Overall, 6% of the sample reported dysmenorrhea, and among those with endometriosis, 30% experienced dysmenorrhea. CONCLUSION: Endometriosis was present in 3.1% of the sample. This finding differs from previous literature as it reports a lower prevalence compared to cisgender women and to other studies on TGD people. This is potentially due to prolonged use of testosterone and early initiation of gender-affirming care (GAC).
引用
- Giacomozzi M, Ruumpol D, de Leeuw R, et al. Endometriosis Among Transgender and Gender Diverse Patients Imaging Study (ETRIS). J Minim Invasive Gynecol. 2025. PMID: 40885532. doi:10.1016/j.jmig.2025.08.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。